Manufacturers, especially pharmaceutical companies, must never mislead consumers by making unfounded claims that can give false hopes to people who are in desperate need to find a cure or prevent an illness.
As with the recent news, Bayer had to learn their lesson the hard way. In a multi-state settlement, Bayer Healthcare had agreed to pay a total of $3.3 to the states of California, Oregon, and Illinois which investigated the company’s claim that their One-A-Day men’s vitamins reduces the risk of having prostate cancer.
In the complaint, the states argued that Bayer should have known that the ingredient mineral selenium in their multivitamins does not, in any way, reduces the risk of incurring prostate cancer as they claimed in their advertisements.
Despite the clinical trial funded by the National Institute of Health in 2008, the company continued to advertise their multivitamin’s potency in television and print until 2009. Bayer even engaged in a promotional relationship with Major League
Baseball wherein the multivitamins designed for men aged over 50 was advertised and endorsed by MLB’s graphics and players.
As included in the settlement, the company will stop advertising their
unsubstantiated claims on the effectiveness of their products without securing reasonable scientific claims.
California’s share of the settlement, which will reach more than $1 million, will go to the state’s consumer protection fund.
These companies should never jeopardize their reputation for making quality products by taking advantage of the consumer’s vulnerability to find ways to lessen the risk of having cancer.
To help you pursue claims involving injuries caused by defective products, consult with knowledgeable personal injury lawyers.
As with the recent news, Bayer had to learn their lesson the hard way. In a multi-state settlement, Bayer Healthcare had agreed to pay a total of $3.3 to the states of California, Oregon, and Illinois which investigated the company’s claim that their One-A-Day men’s vitamins reduces the risk of having prostate cancer.
In the complaint, the states argued that Bayer should have known that the ingredient mineral selenium in their multivitamins does not, in any way, reduces the risk of incurring prostate cancer as they claimed in their advertisements.
Despite the clinical trial funded by the National Institute of Health in 2008, the company continued to advertise their multivitamin’s potency in television and print until 2009. Bayer even engaged in a promotional relationship with Major League
Baseball wherein the multivitamins designed for men aged over 50 was advertised and endorsed by MLB’s graphics and players.
As included in the settlement, the company will stop advertising their
unsubstantiated claims on the effectiveness of their products without securing reasonable scientific claims.
California’s share of the settlement, which will reach more than $1 million, will go to the state’s consumer protection fund.
These companies should never jeopardize their reputation for making quality products by taking advantage of the consumer’s vulnerability to find ways to lessen the risk of having cancer.
To help you pursue claims involving injuries caused by defective products, consult with knowledgeable personal injury lawyers.
